D
Innovative MedTech, Inc.
IMTH
$0.688
$0.31684.95%
D
Sell
1/7/2025Upgraded
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 1/7/2025 due to an increase in the volatility index and total return index.
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 1/7/2025 due to an increase in the volatility index and total return index.
E
Sell
10/16/2024Downgrade
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 10/16/2024 due to a decline in the volatility index, growth index and solvency index. Earnings per share declined from -$0.043 to -$0.2454, operating cash flow declined 259.73% from $22.6 to -$36.1, and EBIT declined 240.19% from -$902 to -$3.07M.
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 10/16/2024 due to a decline in the volatility index, growth index and solvency index. Earnings per share declined from -$0.043 to -$0.2454, operating cash flow declined 259.73% from $22.6 to -$36.1, and EBIT declined 240.19% from -$902 to -$3.07M.
D
Sell
10/4/2024Upgraded
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 10/4/2024 due to an increase in the volatility index.
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 10/4/2024 due to an increase in the volatility index.
E
Sell
9/18/2024Downgrade
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 9/18/2024 due to a significant decline in the growth index and volatility index. EBIT declined 475.26% from -$156.8 to -$902, and earnings per share declined from -$0.0089 to -$0.043.
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 9/18/2024 due to a significant decline in the growth index and volatility index. EBIT declined 475.26% from -$156.8 to -$902, and earnings per share declined from -$0.0089 to -$0.043.
D
Sell
1/9/2024Upgraded
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 1/9/2024 due to a large increase in the growth index, volatility index and solvency index. EBIT increased 81.8% from -$806.7 to -$146.8, earnings per share increased from -$0.0424 to -$0.0078, and the quick ratio increased from 0.11 to 0.13.
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 1/9/2024 due to a large increase in the growth index, volatility index and solvency index. EBIT increased 81.8% from -$806.7 to -$146.8, earnings per share increased from -$0.0424 to -$0.0078, and the quick ratio increased from 0.11 to 0.13.
E
Sell
10/17/2023Downgrade
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 10/17/2023 due to a decline in the volatility index, total return index and valuation index.
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 10/17/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
10/4/2023Upgraded
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 10/4/2023 due to an increase in the volatility index.
Innovative MedTech, Inc. (IMTH) was upgraded to D- from E+ on 10/4/2023 due to an increase in the volatility index.
E
Sell
9/19/2023Downgrade
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 9/19/2023 due to a noticeable decline in the growth index, total return index and volatility index.
Innovative MedTech, Inc. (IMTH) was downgraded to E+ from D- on 9/19/2023 due to a noticeable decline in the growth index, total return index and volatility index.
D
Sell
3/14/2023Downgrade
Innovative MedTech, Inc. (IMTH) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Innovative MedTech, Inc. (IMTH) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/22/2023Upgraded
Innovative MedTech, Inc. (IMTH) was upgraded to D from D- on 2/22/2023 due to an increase in the valuation index.
Innovative MedTech, Inc. (IMTH) was upgraded to D from D- on 2/22/2023 due to an increase in the valuation index.
D
Sell
2/8/2023Downgrade
Innovative MedTech, Inc. (IMTH) was downgraded to D- from D on 2/8/2023 due to a large decline in the efficiency index, growth index and solvency index. Total capital declined 114.27% from $934.2 to -$133.3, the quick ratio declined from 0.13 to 0.07, and debt to equity increased from -1.27 to -0.75.
Innovative MedTech, Inc. (IMTH) was downgraded to D- from D on 2/8/2023 due to a large decline in the efficiency index, growth index and solvency index. Total capital declined 114.27% from $934.2 to -$133.3, the quick ratio declined from 0.13 to 0.07, and debt to equity increased from -1.27 to -0.75.
D
Sell
2/23/2022Upgraded
Innovative MedTech, Inc. (IMTH) was upgraded to D from D- on 2/23/2022 due to a noticeable increase in the total return index, growth index and volatility index. Operating cash flow increased 81.62% from -$192.1 to -$35.3, EBIT increased 51.07% from -$298.2 to -$145.9, and earnings per share increased from -$0.0166 to -$0.0127.
Innovative MedTech, Inc. (IMTH) was upgraded to D from D- on 2/23/2022 due to a noticeable increase in the total return index, growth index and volatility index. Operating cash flow increased 81.62% from -$192.1 to -$35.3, EBIT increased 51.07% from -$298.2 to -$145.9, and earnings per share increased from -$0.0166 to -$0.0127.
D
Sell
11/24/2021Upgraded
Innovative MedTech Inc. (IMTH) was upgraded to D- from on 11/24/2021 due to a substantial increase in the growth index, efficiency index and volatility index. Earnings per share increased from -$0.3342 to -$0.0166, net income increased 63.36% from -$707.6 to -$259.3, and total revenue increased 13.93% from $277.9 to $316.6.
Innovative MedTech Inc. (IMTH) was upgraded to D- from on 11/24/2021 due to a substantial increase in the growth index, efficiency index and volatility index. Earnings per share increased from -$0.3342 to -$0.0166, net income increased 63.36% from -$707.6 to -$259.3, and total revenue increased 13.93% from $277.9 to $316.6.
OTC PK
03/03/2025 9:44AM Eastern
Quotes delayed
